We want to transform healthcare by developing novel vaccines that are lifesaving and improving quality of life around the world.
ExpreS2ion has raised $1.3M in total funding. The most recent round was Post-IPO Equity. The last funding was announced in October 2025.
ExpreS2ion's investors include Horizon Europe, Innovation Fund Denmark, Horizon 2020.
ExpreS2ion is headquartered in Hørsholm, Denmark.
We want to transform healthcare by developing novel vaccines that are lifesaving and improving quality of life around the world.
ExpreS2ion is at the Post-IPO Equity stage.
Free to use in articles, research, and reference works. Stable URL — will not change. Data on this page last updated .
"ExpreS2ion — Funding & Investors." VCBacked, October 6, 2025, https://www.vcbacked.co/company/expres2ion. Accessed August 13, 2026.
VCBacked. (2025). ExpreS2ion — Funding & Investors. Retrieved August 13, 2026, from https://www.vcbacked.co/company/expres2ion
{{cite web |title=ExpreS2ion — Funding & Investors |url=https://www.vcbacked.co/company/expres2ion |website=VCBacked |access-date=August 13, 2026}}Profile data sourced and verified per the VCbacked methodology · Last funding round dated